RecallHawk

ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE)

MARKSANS PHARMA

Summary

FDA approved ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE) by MARKSANS PHARMA. ANDA (Generic) approval (Manufacturing (CMC)) on 2023-04-13. TABLET, ORAL.

Details

Source

Drug Approval

External ID

ANDA078933-5

Action Date

2023-04-13

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

ALLERGY RELIEF (generic: CETIRIZINE HYDROCHLORIDE), TABLET, ORAL. Application: ANDA078933

Context & Analysis

MARKSANS PHARMA has 8 FDA actions in our database.

Frequently Asked Questions

How often does MARKSANS PHARMA have FDA actions?

MARKSANS PHARMA has 8 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA078933-5" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions